Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Javier Garcia-Corbacho, MD, Hospital Clinic Barcelona, Barcelona, Spain, outlines the potential of circulating tumor DNA (ctDNA) for diagnosis and for monitoring response to treatment and disease evolution and predicts that it will soon be used in standard clinical practice. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.
Disclosures
Dr Garcia-Corbacho declares participation in multiple clinical trials and meetings as speaker (advisory role) and financial sponsor support for meeting attendance.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.